Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis: epidemiologic study in a real-world analysis of the French national health insurance database

J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e259-e262. doi: 10.1111/jdv.16238. Epub 2020 Mar 4.

Authors

C Grodner¹, M Mezzarobba², A Weill^{2

3}, E Sbidian^{3

4

5}

Affiliations

¹ Département de Dermatologie, AP-HP, Hôpitaux universitaires Henri Mondor, UPEC, Créteil, France.
² Caisse Nationale d'Assurance Maladie des Travailleurs Salariés (CNAM), Paris, France.
³ GIS-EPIPHARE, Groupement d'intérêt scientifique Epidémiologie des produits de santé, ANSM-CNAM, Paris, France.
⁴ Centre d'Investigation Clinique 1430, INSERM, Créteil, France.
⁵ EA 7379 EpidermE, Université Paris-Est Créteil, UPEC, Créteil, France.

PMID: 31991503
DOI: 10.1111/jdv.16238

No abstract available

Publication types

Letter

MeSH terms

Administration, Topical
Databases, Factual
Epidemiologic Studies
Humans
National Health Programs
Psoriasis* / drug therapy
Psoriasis* / epidemiology
Steroids / therapeutic use

Substances

Steroids

Grants and funding

French National Health Insurance Fund (CNAM)